Compare PFX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFX | ARAY |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.7M | 100.5M |
| IPO Year | N/A | 2007 |
| Metric | PFX | ARAY |
|---|---|---|
| Price | $44.42 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 1.5K | ★ 1.2M |
| Earning Date | 02-06-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | $25,262,322.00 | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | $21.21 | ★ N/A |
| Revenue Growth | ★ 13.89 | 1.51 |
| 52 Week Low | $41.00 | $0.78 |
| 52 Week High | $57.40 | $2.95 |
| Indicator | PFX | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 44.48 |
| Support Level | $43.01 | $0.86 |
| Resistance Level | $45.70 | $0.93 |
| Average True Range (ATR) | 0.94 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 45.04 | 64.68 |
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.